Effect of imipramine on depression and immune status in a sample of men with HIV infection



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Rabkin, J. G.
	Articles by Harrison, W. M.
	Search for Related Content



	PubMed Citation
	Articles by Rabkin, J. G.
	Articles by Harrison, W. M.

Am J Psychiatry 1990; 147:495-497
Copyright © 1990 by American Psychiatric Association

REGULAR ARTICLES

Effect of imipramine on depression and immune status in a sample of men with HIV infection

JG Rabkin and WM Harrison
New York State Psychiatric Institute, NY 10032.

Eleven men with major depression and human immunodeficiency virus (HIV) infection underwent an open trial of imipramine. Eight of nine (89%) who completed 12 weeks responded. The mean decline in T4 cells from baseline was 100 at week 12 and 16 at week 26. No major exacerbations of HIV infection occurred.

This article has been cited by other articles:

A. J. Elliott, K. K. Uldall, K. Bergam, J. Russo, K. Claypoole, and P. P. Roy-Byrne
Randomized, Placebo-Controlled Trial of Paroxetine Versus Imipramine in Depressed HIV-Positive Outpatients
Am J Psychiatry, March 1, 1998; 155(3): 367 - 372.
[Abstract] [Full Text]

Get information about faster international access.